• Skip to main content

The Source for CFO Thought Leadership

  • About Us
  • Podcast
    • Articles
  • Book
  • Video Episodes
  • Planning Aces

Halozyme Announces Plans For CFO Transition, Names Laurie Stelzer CFO

SAN DIEGO, June 5, 2015 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO), an oncology biotech company, today announced its chief financial officer David Ramsay will retire this summer, and named biotech veteran Laurie Stelzer as his successor. Stelzer will assume CFO duties on June 15 and will work with Ramsay through a transition period. “Since last…

Filed Under: Uncategorized

  • iTunes
  • Youtube
  • Linkedin

Copyright © 2025 · CFO Thought Leader / Log in